Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients With Curatively Resected Ampulla of Vater Cancer
PLoS ONE - United States
doi 10.1371/journal.pone.0151406
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 14, 2016
Authors
Publisher
Public Library of Science (PLoS)